DAY ONE BIOPHARMACEUTICALS I's ticker is DAWN and the CUSIP is 23954D109. A total of 129 filers reported holding DAY ONE BIOPHARMACEUTICALS I in Q3 2023. The put-call ratio across all filers is 2.14 and the average weighting 0.4%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Canaan Partners XI LLC | 2,491,561 | $30,571,453 | 26.81% |
| Atlas Venture Life Science Advisors, LLC | 7,608,394 | $93,354,994 | 14.46% |
| DAFNA Capital Management LLC | 586,463 | $7,195,901 | 2.24% |
| Nicholas Investment Partners, LP | 2,188,654 | $26,854,785 | 2.01% |
| RA Capital Management | 7,809,852 | $95,826,884 | 1.89% |
| BRAIDWELL LP | 3,715,573 | $45,590,081 | 1.44% |
| PFM Health Sciences, LP | 2,224,598 | $27,295,817 | 1.29% |
| SPHERA FUNDS MANAGEMENT LTD. | 530,000 | $6,503,100 | 1.18% |
| COMMODORE CAPITAL LP | 739,661 | $9,075,640 | 1.06% |
| Parkman Healthcare Partners LLC | 466,408 | $5,722,826 | 1.05% |
| Boxer Capital, LLC | 1,189,943 | $14,600,601 | 0.78% |
| Samsara BioCapital, LLC | 196,425 | $2,410,135 | 0.74% |
| AlphaCentric Advisors LLC | 95,000 | $1,165,650 | 0.66% |
| APIS CAPITAL ADVISORS, LLC | 29,000 | $355,830 | 0.46% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,269,992 | $15,582,802 | 0.34% |
| Artal Group S.A. | 500,000 | $6,135 | 0.26% |
| Simplify Asset Management Inc. | 175,018 | $2,147,471 | 0.25% |
| TimesSquare Capital Management, LLC | 1,142,610 | $14,020 | 0.22% |
| Polar Capital Holdings Plc | 1,935,000 | $23,742,450 | 0.18% |
| VIKING GLOBAL INVESTORS LP | 2,558,563 | $31,393,568 | 0.13% |
External links
This page lists DAY ONE BIOPHARMACEUTICALS I's shareholders in Q3 2023. To view DAY ONE BIOPHARMACEUTICALS I's shareholder history, click here.